Comprehensive mutational profiling of core binding factor acute myeloid leukemiaNicolas Duployez, Claude Preudhomme, Martin Figeac et al.|Blood|2016Cited by 245
Frequent ASXL2 mutations in acute myeloid leukemia patients with t(8;21)/RUNX1-RUNX1T1 chromosomal translocationsJean‐Baptiste Micol, Éric Jourdan, Nicolas Duployez et al.|Blood|2014Cited by 127
<i>IDH1/2</i>but not<i>DNMT3A</i>mutations are suitable targets for minimal residual disease monitoring in acute myeloid leukemia patients: a study by the Acute Leukemia French AssociationHouria Debarri, Claude Preudhomme, Delphine Lebon et al.|Oncotarget|2015Cited by 98
Next-generation sequencing of FLT3 internal tandem duplications for minimal residual disease monitoring in acute myeloid leukemiaJean‐Emmanuel Bibault, Claude Preudhomme, Martin Figeac et al.|Oncotarget|2015Cited by 57
<i>Neurofibromatosis‐1</i> gene deletions and mutations in de novo adult acute myeloid leukemiaElise Boudry‐Labis, Catherine Roche‐Lestienne, Olivier Nibourel et al.|American Journal of Hematology|2013Cited by 49